Trial Profile
A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Dec 2014
Price :
$35
*
At a glance
- Drugs Difluprednate (Primary)
- Indications Postoperative inflammation
- Focus Therapeutic Use
- Sponsors Sirion Therapeutics
- 23 Dec 2014 New trial record